Literature DB >> 7851270

Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus.

F Innocenti1, A Fabbri, R Anichini, S Tuci, G Pettinà, F Vannucci, L A De Giorgio, G Seghieri.   

Abstract

Abnormalities of pulmonary function tests have been described in type 1 (insulin-dependent) diabetes mellitus (IDDM). To better characterise such abnormalities and to verify whether these latter are associated with the presence of diabetic microvascular disease we compared 23 non-smoking patients who had IDDM with 24 non-smoking healthy control subjects strictly matched for sex, age, and body mass index. Compared with controls, diabetic patients had a reduced forced vital capacity (FVC) (87.5 +/- 13.1% vs. 96.4 +/- 13.6% of the predicted; P = 0.03) and forced expiratory volume in 1 s (FEV1) (90.5 +/- 17.7% vs. 101.2 +/- 13.2% of the predicted; P = 0.02). While within the group of patients the presence of retinopathy and autonomic neuropathy were not associated with modifications of pulmonary function tests, those with altered urinary albumin excretion rate (AER > or = 20 micrograms/min; range 21-589) (n = 7) had a significantly lower pulmonary diffusion capacity (DLCO) than the 16 normoalbuminuric subjects (62.6 +/- 7.2% vs. 88.7 +/- 20.1% of the predicted; P = 0.01). Moreover, in the group of patients, DLCO was inversely related with AER (r = -0.43; P = 0.04). In conclusion, IDDM is characterised by reduced FVC and FEV1, while a significant decrease in DLCO may be considered as selectively associated with renal disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7851270     DOI: 10.1016/0168-8227(94)90004-3

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Effect of duration of disease on ventilatory function in an ethnic Saudi group of diabetic patients.

Authors:  Sultan A Meo; Abdul Majeed Al Drees; Jehangeer Ahmed; Sayed Fayaz Ahmed Shah; Khalid Al-Regaiey; Ashraf Husain; Khalid Al-Rubean
Journal:  J Diabetes Sci Technol       Date:  2007-09

2.  Type 1 Diabetes Duration Decreases Pulmonary Diffusing Capacity during Exercise.

Authors:  Michelle J Lee; J Richard Coast; Steven C Hempleman; J Christopher Baldi
Journal:  Respiration       Date:  2016-01-13       Impact factor: 3.580

Review 3.  The diabetic lung--a new target organ?

Authors:  Dario Pitocco; Leonello Fuso; Emanuele G Conte; Francesco Zaccardi; Carola Condoluci; Giuseppe Scavone; Raffaele A Incalzi; Giovanni Ghirlanda
Journal:  Rev Diabet Stud       Date:  2012-05-10

4.  Evaluation of pulmonary function changes in children with type 1 diabetes mellitus in Upper Egypt.

Authors:  Ismail L Mohamad; Khaled Saad; Ali Abdel-Azeem; Sherif A A Mohamed; Hisham A K Othman; Khaled A Abdel Baseer; Ahmad F Thabet; Amira A El-Houfey
Journal:  Ther Adv Endocrinol Metab       Date:  2015-06       Impact factor: 3.565

Review 5.  When kidneys and lungs suffer together.

Authors:  Claudio Sorino; Nicola Scichilone; Claudio Pedone; Stefano Negri; Dina Visca; Antonio Spanevello
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

6.  Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study.

Authors:  Yuan Kao; Chien-Chin Hsu; Shih-Feng Weng; Hung-Jung Lin; Jhi-Joung Wang; Shih-Bin Su; Chien-Cheng Huang; How-Ran Guo
Journal:  Endocrine       Date:  2015-06-27       Impact factor: 3.633

7.  Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes.

Authors:  Courtney M Wheatley; James C Baldi; Nicholas A Cassuto; William T Foxx-Lupo; Eric M Snyder
Journal:  Eur J Appl Physiol       Date:  2010-10-10       Impact factor: 3.078

8.  Diffusing capacity for carbon monoxide in children with type 1 diabetes.

Authors:  M P Villa; M Montesano; M Barreto; J Pagani; M Stegagno; G Multari; R Ronchetti
Journal:  Diabetologia       Date:  2004-11-24       Impact factor: 10.122

9.  Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Authors:  Samantha F Ehrlich; Charles P Quesenberry; Stephen K Van Den Eeden; Jun Shan; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

Review 10.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.